Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level

Anne Linge; R van Os; Nienke Hoekstra; Ben Heijmen; Linda Stienstra; Alof Dallenga; JG Wolbers; Alejandra Mendez Romero

doi:10.1186/s13014-018-1202-z

Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level

Anne Linge, R van Os, Nienke Hoekstra, Ben Heijmen, Linda Stienstra, Alof Dallenga, JG Wolbers, Alejandra Mendez Romero

Research output: Contribution to journal › Article › Academic › peer-review

18 Citations (Scopus)

9 Downloads (Pure)

Original language	Undefined/Unknown
Article number	253
Journal	Radiation Oncology
Volume	13
DOIs	https://doi.org/10.1186/s13014-018-1202-z
Publication status	Published - 2018

Research programs

EMC MM-03-32-04
EMC OR-01-62-02

Access to Document

10.1186/s13014-018-1202-z

REPUB_113520_OA.pdfFinal published version, 1.15 MB

http://hdl.handle.net/1765/113520

Cite this

@article{64b7649971b745afb82667e16aa4b9db,

title = "Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level",

author = "Anne Linge and {van Os}, R and Nienke Hoekstra and Ben Heijmen and Linda Stienstra and Alof Dallenga and JG Wolbers and {Mendez Romero}, Alejandra",

year = "2018",

doi = "10.1186/s13014-018-1202-z",

language = "Undefined/Unknown",

volume = "13",

journal = "Radiation Oncology",

issn = "1748-717X",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level

AU - Linge, Anne

AU - van Os, R

AU - Hoekstra, Nienke

AU - Heijmen, Ben

AU - Stienstra, Linda

AU - Dallenga, Alof

AU - Wolbers, JG

AU - Mendez Romero, Alejandra

PY - 2018

Y1 - 2018

U2 - 10.1186/s13014-018-1202-z

DO - 10.1186/s13014-018-1202-z

M3 - Article

C2 - 30583739

SN - 1748-717X

VL - 13

JO - Radiation Oncology

JF - Radiation Oncology

M1 - 253

ER -